Enzyvant Inc.
Enzyvant develops therapeutics for treatment of rare diseases. Their focuses are RVT-802, an investigational tissue-based therapy for immune deficiency resulting from DiGeorge Anomaly, and RVT-801, an enzyme replacement therapy to treat Farber disease.
Company Location
WeWork - One City Place, 110 Corcoran St.
Durham
NC
27701
County
Region
Company Details
Company type
Year founded
2016
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)